| Date Filed | Type | Description |
| 08/18/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results|
Docs:
|
"PROPRIETARY AND CONFIDENTIAL ©2023 ENFUSION. ALL RIGHTS RESERVED. Disclaimer 2 Forward-Looking Statements Statements we make in this presentation may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 , including expectations regarding future financial performance. These forward-looking statements are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “could,” “will,”..." |
|
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
8-K
| Unregistered Sales of Equity Securities Interactive Data |
| 05/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Quarterly results |
| 05/03/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/01/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/01/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/01/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/10/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/09/2023 |
SC 13G/A
| BROWN CAPITAL MANAGEMENT LLC reports a 10.5% stake in Enfusion Inc. |
| 03/07/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 02/24/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/14/2023 |
SC 13G/A
| Movchan Oleg reports a 16.8% stake in Enfusion, Inc. |
| 02/14/2023 |
SC 13G/A
| Dragoneer Investment Group, LLC reports a 8.7% stake in ENFUSION, INC. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/11/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/19/2022 |
8-K
| Quarterly results |
| 12/05/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 11/30/2022 |
8-K
| Quarterly results |
|